Global AI In Medical Imaging Market: Forecasts, Competitive Landscape, And Reimbursement-Driven Monetization, 2024A-2035E Enterprise And Cloud Adoption Fuels Growth
Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Global AI in Medical Imaging Horizon: Forecasts, Competitive Architecture, and Reimbursement-Driven Monetization, 2024A-2035E" has been added to ResearchAndMarkets.com's offering.
The report delivers a global analysis of artificial intelligence in medical imaging from 2024A-2035E, combining market sizing, segment forecasts, reimbursement-driven monetization, competitive dynamics, regulatory developments and strategic implications. Designed for vendors, healthcare providers and investors, it examines the commercial evolution of medical imaging AI across CT, MRI, X-ray and digital radiography, mammography and DBT, ultrasound, nuclear imaging and PET.
Market value is shifting from stand-alone algorithms toward workflow integration, enterprise deployment, recurring software revenue, reimbursement maturity, cloud infrastructure and pay-per-use models. The report focuses on monetization, explaining why AI tools with comparable technical capabilities or regulatory profiles can generate significantly different commercial outcomes. Key variables include payer coverage, clinical evidence, procurement structures, workflow integration, buyer type and the ability to scale across enterprise environments.
Key Questions Addressed
- How is the global medical imaging AI market structured by modality, clinical area, application, technology layer, revenue stream, end user and region? Which medical imaging AI categories offer the strongest monetization potential through 2035E? How do reimbursement policies influence adoption, pricing, competitive defensibility and market maturity? Where are cloud and pay-per-use models gaining ground against installed and hardware-embedded AI? How are foundation models and multi-condition platforms affecting single-indication vendors? Which companies control the enterprise, clinical, infrastructure and reimbursement layers that shape commercialization?
Medical Imaging AI Market Outlook
The report presents a reconciled 2024A-2035E market model spanning modality, clinical area, clinical application, technology layer, revenue stream, end-user organization, geography and reimbursement tier. Base, Bull and Bear scenarios, supported by sensitivity analysis, provide a structured outlook for market development.
Base-case growth is driven by reimbursement expansion, enterprise platform adoption, AI-enabled productivity, cloud deployment and disease-specific quantitative analytics. The reimbursement framework distinguishes mature reimbursed AI, developing reimbursement categories, non-reimbursed productivity AI, and hardware-embedded or out-of-tier AI. These categories draw from different budgets and require distinct pricing, evidence and commercialization strategies.
Key Market Trends
Workflow control is becoming a primary competitive advantage. Commercial leadership increasingly depends on ownership of workflow, clinical evidence, reimbursement documentation and governance rather than model novelty alone. Reimbursement is reshaping market structure. Payment pathways separate AI that can be billed as a clinical service from products funded through productivity, scanner attach or enterprise software budgets. Cardiac CT analytics illustrates how payment policy can accelerate category development. Foundation models are increasing pressure on narrow solutions. Multi-condition triage and foundation-model platforms are challenging single-indication products and contributing to market consolidation. Enterprise platforms and provider networks are gaining influence. Enterprise imaging and PACS vendors, provider-owned AI networks and reimbursed quantitative specialists increasingly determine which algorithms are deployed, governed and paid for. Cloud and pay-per-use adoption is expanding. These models are changing medical imaging AI pricing, deployment and governance while supporting broader access and scalable implementation. Evidence and governance are central procurement criteria. Mammography screening evidence, AI monitoring requirements and regulatory frameworks including FDA PCCP, the EU AI Act and MDR increasingly influence purchasing decisions.Competitive Landscape
Competition is assessed across imaging OEMs; enterprise imaging and PACS, RIS and VNA platforms; AI-native clinical platforms; reimbursed quantitative analytics companies; breast and oncology AI vendors; reconstruction and acquisition AI providers; reporting and workflow automation companies; AI orchestration and governance platforms; cloud infrastructure providers; and provider-network AI platforms. The report also evaluates M&A and partnership implications across these control points.
Companies discussed include GE HealthCare, Siemens Healthineers, Philips, Canon Medical, Fujifilm, United Imaging, Pro Medicus, Sectra, Intelerad, Agfa HealthCare, Aidoc, Viz.ai, RapidAI, Qure.ai, Annalise.ai, DeepHealth / RadNet, HeartFlow, Cleerly, Elucid, Circle Cardiovascular Imaging, Lunit, iCAD, ScreenPoint, Hologic, Vara, Rad AI, Microsoft / Nuance, deepc, CARPL.ai, Ferrum Health, Blackford, Incepto, AWS, Microsoft Azure, Google Cloud and NVIDIA.
Report Coverage
- Global market model: TAM, SAM and expected-market analysis for 2024A-2035E, supported by Base, Bull, Bear and sensitivity scenarios. Segment forecasts: Analysis by region, modality, clinical area, application, revenue stream, technology layer, end-user organization and reimbursement tier. Reimbursement and regulation: Cardiac CT reimbursement, quantitative analytics, mammography evidence pathways, FDA, De Novo, Breakthrough Device, PCCP, EU AI Act and MDR, NMPA and PMDA considerations. Enterprise economics: Coverage of enterprise imaging, PACS, reporting, orchestration, AI governance, foundation-model strategy, cloud deployment and recurring software monetization. Provider economics: Assessment of provider-owned AI networks, teleradiology services and outpatient imaging organizations. Strategic planning: Competitive positioning, M&A opportunities, partnership priorities and execution playbooks by stakeholder type.
Intended Audience
- Imaging OEM and enterprise imaging executives Medical imaging AI vendors and workflow software companies Provider networks, imaging centers, radiology groups and teleradiology operators Cloud and infrastructure providers serving healthcare imaging Corporate strategy, corporate development and M&A teams Private equity firms, investors and advisory organizations
The report supports market-entry planning, product strategy, investment analysis, corporate development and go-to-market decisions. Readers can use it to compare opportunities across modalities and clinical applications, assess reimbursement exposure, identify high-potential medical imaging AI segments, benchmark competitive positioning and evaluate partnership or acquisition options through 2035E.
Companies Featured
- Agfa HealthCare Aidoc Annalise.ai AWS Blackford Canon Medical CARPL.ai Circle Cardiovascular Imaging Cleerly deepc DeepHealth / RadNet Elucid Ferrum Health Fujifilm GE HealthCare Google Cloud HeartFlow Hologic iCAD Incepto Intelerad Lunit Microsoft / Nuance Microsoft Azure NVIDIA Philips Pro Medicus Qure.ai Rad AI RapidAI ScreenPoint Sectra Siemens Healthineers United Imaging Vara Viz.ai
For more information about this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment